Role of myeloid cells in tumor angiogenesis and growth

被引:130
作者
Shojaei, Farbod [1 ]
Zhong, Cuiling [1 ]
Wu, Xiumin [1 ]
Yu, Lanlan [1 ]
Ferrara, Napoleone [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1016/j.tcb.2008.06.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cells of the innate immune system have a key role in maintaining homeostasis by providing the first line of defense against many pathogens. Innate immunity can also modulate the activity of acquired immunity by several mechanisms. However, subsets of myeloid cells can facilitate tumor growth, because these cells produce angiogenic factors and can also prevent the immune system from attacking tumor cells. Recent studies also emphasize the role of myeloid cells in mediating refractoriness to anti-VEGF treatments. This function of myeloid cells occurs through a proangiogenic pathway that is, at least in part, driven by the secreted protein Bv8. This review summarizes recent findings on the complex role of bone marrow-derived cells in tumor growth.
引用
收藏
页码:372 / 378
页数:7
相关论文
共 90 条
[1]   Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: Role of bone marrow-derived myelomonocytic cells [J].
Ahn, G-One ;
Brown, J. Martin .
CANCER CELL, 2008, 13 (03) :193-205
[2]   Lymphangiogenesis in development and human disease [J].
Alitalo, K ;
Tammela, T ;
Petrova, TV .
NATURE, 2005, 438 (7070) :946-953
[3]   Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer [J].
Almand, B ;
Clark, JI ;
Nikitina, E ;
van Beynen, J ;
English, NR ;
Knight, SC ;
Carbone, DP ;
Gabrilovich, DI .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :678-689
[4]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[5]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[6]   Innate immunity - Innate pathways that control acquired immunity [J].
Bendelac, A ;
Fearon, DT .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :1-3
[7]   Vascular remodeling and clinical resistance to antiangiogenic cancer therapy [J].
Bender, JG ;
Cooney, EM ;
Kandel, JJ ;
Yamashiro, DJ .
DRUG RESISTANCE UPDATES, 2004, 7 (4-5) :289-300
[8]   Celecoxib for the prevention of sporadic colorectal adenomas [J].
Bertagnolli, Monica M. ;
Eagle, Craig J. ;
Zauber, Ann G. ;
Redston, Mark ;
Solomon, Scott D. ;
Kim, KyungMann ;
Tang, Jie ;
Rosenstein, Rebecca B. ;
Wittes, Janet ;
Corle, Donald ;
Hess, Timothy M. ;
Woloj, G. Mabel ;
Boisserie, Frederic ;
Anderson, William F. ;
Viner, Jaye L. ;
Bagheri, Donya ;
Burn, John ;
Chung, Daniel C. ;
Dewar, Thomas ;
Foley, T. Raymond ;
Hoffman, Neville ;
Macrae, Finlay ;
Pruitt, Ronald E. ;
Saltzman, John R. ;
Salzberg, Bruce ;
Sylwestrowicz, Thomas ;
Gordon, Gary B. ;
Hawk, Ernest T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :873-884
[9]   Do autochthonous tumors interfere with effector T cell responses? [J].
Blankenstein, Thomas .
SEMINARS IN CANCER BIOLOGY, 2007, 17 (04) :267-274
[10]   Nitric oxide and the immune response [J].
Bogdan, C .
NATURE IMMUNOLOGY, 2001, 2 (10) :907-916